Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

37.63
Delayed Data
As of Feb 05
 -0.48 / -1.26%
Today’s Change
30.93
Today|||52-Week Range
45.35
-1.39%
Year-to-Date

Today’s Trading

Previous close38.11
Today’s open37.97
Day’s range37.29 - 38.26
Volume142,900
Average volume (3 months)145,331
Market cap$550.8M
Dividend yield--
Data as of 02/05/2016

Growth & Valuation

Earnings growth (last year)+80.58%
Earnings growth (this year)-27.19%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+40.64%
P/E ratio20.7
Price/Sales5.89
Price/Book3.14

Competitors

 Today’s
change
Today’s
% change
ATRCAtriCure Inc-0.83-4.67%
CERSCerus Corp+0.05+0.93%
KTWOK2M Group Holdings I...-0.39-3.00%
LDRHLDR Holding Corp-0.84-4.65%
Data as of 02/05/2016

Financials

Next reporting dateFebruary 24, 2016
EPS forecast (this quarter)$0.54
Annual revenue (last year)$105.6M
Annual profit (last year)$38.3M
Net profit margin36.29%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Francesco J. Luppino
Corporate headquarters
Bedford, Massachusetts

Forecasts

Partner Offers